<?xml version="1.0" ?>
<document id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3">
  <chunk id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c0" text="viruses Gemcitabine and Nucleos(t)ide Synthesis Inhibitors Are Broad-Spectrum Antiviral Drugs that Activate Innate Immunity">
    <entity charOffset="38-47" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c0.e0" ontology_id="GO_0009058" text="Synthesis" type="gene_function"/>
    <entity charOffset="108-123" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c0.e1" ontology_id="GO_0045087" text="Innate Immunity" type="gene_function"/>
  </chunk>
  <chunk id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1" text="Nucleoside analogs have been frequently identified as antiviral agents. In recent years, gemcitabine, a cytidine analog in clinical use for the treatment of many solid tumors, was also shown to have antiviral activity against a broad range of viruses. Nucleoside analogs generally interfere with cellular nucleos(t)ide synthesis pathways, resulting in the depletion or imbalance of (d)NTP pools. Intriguingly, a few recent reports have shown that some nucleoside analogs, including gemcitabine, activated innate immunity, inducing the expression of interferon-stimulated genes, through nucleos(t)ide synthesis inhibition. The precise crosstalk between these two independent processes remains to be determined. Nonetheless, we summarize the current knowledge of nucleos(t)ide synthesis inhibition-related innate immunity and propose it as a newly emerging antiviral mechanism of nucleoside analogs.">
    <entity charOffset="319-328" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e0" ontology_id="GO_0009058" text="synthesis" type="gene_function"/>
    <entity charOffset="369-378" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e1" ontology_id="HP_0002172" text="imbalance" type="phenotype"/>
    <entity charOffset="505-520" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e2" ontology_id="GO_0045087" text="innate immunity" type="gene_function"/>
    <entity charOffset="600-609" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e3" ontology_id="GO_0009058" text="synthesis" type="gene_function"/>
    <entity charOffset="775-784" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e4" ontology_id="GO_0009058" text="synthesis" type="gene_function"/>
    <entity charOffset="804-819" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e5" ontology_id="GO_0045087" text="innate immunity" type="gene_function"/>
    <pair e1="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e0" e2="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e1" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.p0" relation="true"/>
    <pair e1="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e1" e2="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e2" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.p1" relation="true"/>
    <pair e1="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e1" e2="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e3" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.p2" relation="true"/>
    <pair e1="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e1" e2="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e4" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.p3" relation="true"/>
    <pair e1="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e1" e2="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.e5" id="f1e1e2511e051195c8327a56d5c311a2dd4ab6b3.c1.p4" relation="true"/>
  </chunk>
</document>
